Delivery Order SPE2DB22D2005-SPE2DB25FJGQ8
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 mg/100 mL of Ropivacaine 0.2% in 100 mL vials, with a ceiling value of $1,634.70 and a completion date of February 13, 2025. This is a firm fixed-price Delivery Order contract, which is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $14,089.80, is for the delivery of 400 mg/200 mL Ropivacaine 0.2% injectable medication. The contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 150 mg/30 mL vials of the anesthetic drug ropivacaine 0.5%, with a ceiling value of $1,891.03 and a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 400 mg/200 ml vials of the anesthetic medication Ropivacaine 0.2%, with a ceiling value of $1,816.72 and a completion date of February 14, 2024. The contract is a firm fixed-price Indefinite Delivery Contract vehicle, with no set-aside designation, that allows the DLA to procure a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,731.07, is for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This contract award is for the delivery of 400 mg/200 mL vials of ropivacaine 0.2% solution, a local anesthetic medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,873.51, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 27, 2023 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 ml ropivacaine (a pain medication) at a ceiling value of $1,823.16. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,997.26 firm fixed-price delivery order is for the supply of 100 mL bottles of 0.2% Ropivacaine, a local anesthetic medication. The contract has a completion date of February 4, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/200 mL vials of the anesthetic medication ropivacaine 0.2%. The delivery order, valued at $5,194.15, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for $2,388.99 to provide 400 mg/200 mL vials of the anesthetic drug ropivacaine 0.2%. The contract has a firm fixed price and an ultimate completion date of March 12, 2024. This is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...